Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemigliptin add-on in type 2 diabetes (SOLUTION)
NCT03842267Phase 3Completed
- Sponsor
- LG Chem
- Start
- May 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of gemigliptin in type 2 diabetes mellitus (T2DM), sponsored by LG Chem. Started May 2019; status: completed.
02
Drugs
gemigliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT03842267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03842267.